UN Reports Nearly 20 Million Measles Deaths Averted in Africa Since 2000
A new analysis by the World Health Organization (WHO) and Gavi, the Vaccine Alliance, reveals that nearly 20 million measles deaths have been averted in Africa since 2000 due to expanded immunization efforts. Vaccination coverage for measles has increased significantly, halving deaths and reducing cases by 40 percent, though progress remains uneven. The report highlights the need for sustained investment to meet global immunization targets by 2030.
Why this is uncovered
UN News reports that nearly 20 million measles deaths have been averted in Africa since 2000 due to immunization efforts, a major public health success. Mainstream media overlooks this positive development, focusing instead on conflict and crisis narratives in the region, missing a chance to highlight effective health interventions.
UN Reports Major Progress in Measles Prevention Across Africa
A groundbreaking analysis released by the World Health Organization (WHO) and Gavi, the Vaccine Alliance, shows that nearly 20 million measles deaths have been prevented in Africa since 2000, marking a significant public health achievement. Published on Wednesday, the report is the first detailed examination of immunization targets in the region, documenting both progress and persistent challenges in expanding vaccine coverage against a range of preventable diseases UN News.
The data covers the period from 2000 to 2024, during which vaccination efforts intensified across the continent. A key factor in this success was the introduction of a second dose of measles-containing vaccine into routine programs in 44 African countries. As a result, measles vaccination coverage surged from just 5 percent in 2000 to 55 percent by 2024. Additionally, supplemental inoculation campaigns delivered 622 million vaccinations, contributing to a 50 percent reduction in measles deaths and a 40 percent drop in overall cases in the region UN News.
The impact of these efforts is evident in specific milestones. In 2023 and 2024, nine countries reported consistently low measles incidence rates. Furthermore, in 2025, Cabo Verde, Mauritius, and the Seychelles became the first sub-Saharan African nations to be verified as having eliminated measles and rubella, a significant step forward in the fight against these diseases UN News.
“Africa has made remarkable progress in less than a generation, expanding immunization and saving millions of young lives,” said Dr. Mohamed Janabi, WHO Regional Director. However, he cautioned that progress is uneven and slowing in some areas, leaving many children unprotected as key targets under the 2030 Immunization Agenda remain unmet. The agenda, a global strategy, aims for 90 percent vaccination coverage at four critical life stages to protect against diseases like diphtheria, pertussis, measles, and human papillomavirus (HPV). Currently, Africa falls short of this goal, with disparities in coverage across countries and communities UN News.
Beyond measles, the report highlights broader immunization gains. Routine schedules now protect against 13 vaccine-preventable diseases, up from eight in 2000. Meningitis deaths have decreased by nearly 40 percent, and the malaria vaccine has been introduced in 25 countries. In 2024 alone, at least 1.9 million lives were saved through vaccination, with 42 percent of those attributed to measles vaccines UN News.
Despite these achievements, challenges persist. Many children remain unvaccinated due to uneven access, and the region is off track to meet the 2030 targets. WHO and Gavi emphasize the need for continued investment and strong political commitment to sustain these gains and protect future generations. They are collaborating with governments to expand coverage and accelerate the introduction of new vaccines, such as those for malaria and HPV UN News.
“This analysis demonstrates the immense life-saving power of vaccines when immunization is prioritized as a matter of policy,” said Dr. Sania Nishtar, CEO of Gavi. Yet, she acknowledged that the uneven outcomes reflect broader systemic issues that must be addressed to ensure no child is left behind UN News.
This report underscores a rare positive development in African public health, often overshadowed by narratives of conflict and crisis in mainstream coverage. The success in averting millions of measles deaths highlights the effectiveness of coordinated immunization efforts and the potential for further progress with sustained global support.
Sources
More in Health
A recent article in The Lancet explores the role of MEK inhibitors in treating BRAF-driven cancers, noting their limited clinical impact due to toxicity, resistance, and modest durability as a monotherapy. The study highlights severe adverse effects and the emerging importance of predictive biomarkers for patient selection and monitoring. This critical therapeutic challenge remains underreported in mainstream media despite its significance for cancer treatment advancements.
18 Apr 2026
A groundbreaking study of ancient human DNA, published in Nature, has shown that human evolution accelerated significantly over the past 10,000 years in West Eurasia. Researchers identified nearly 500 gene variants shaped by natural selection, particularly after the advent of agriculture, with many linked to disease resistance. This finding offers new insights into how farming and associated lifestyle changes influenced human biology.
18 Apr 2026
A recent study in mice, published in Cell, suggests that B cells, a key component of the immune system, play a surprising role in enhancing exercise endurance and muscle performance. Conducted by researchers at Tsinghua University, the findings reveal a previously unknown connection between immune cells and metabolism during physical activity. This discovery could open new avenues for health and fitness research, though its applicability to humans remains to be explored.
18 Apr 2026